The opioid addiction crisis is rising out of control and leading to an increase in political and market pressure on drug companies from regulators, legislators, insurers, physicians, and patient advocacy groups.
Our
4th Human Abuse Liability & Abuse-Deterrent Formulations conference is the largest industry event specifically focused on the full spectrum of challenges and goals required to create and market drugs with lowered abuse potential. No other event goes into as much detail about the preclinical development of abuse-deterrent drugs and delivery mechanisms, clinical trial design, and building strong, reliable networks with every stakeholder throughout the regulatory and market access community.
Top Five Reasons to Attend
- All-new insight on how to gather and use real-world evidence to make a strong case for your ADFs among payers and clinicians
- Technical analysis of the next generation of less addictive opioids
- Up-to-date review of the latest FDA regulatory guidelines and public meetings
- Detailed survey of new state legislation about opioids and manufacturers
- In-depth, interactive workshop about preparing for an FDA advisory committee meeting
Speakers
- Jeremy Adler, COO, PACIFIC PAIN MEDICINE
- Charles Argoff, Professor of Neurology, ALBANY MEDICAL CENTER
- David Baker, Interim CEO, ALCOBRA
- Michael Barnes, Executive Director, CENTER FOR LAWFUL ACCESS AND ABUSE DETERRENCE
- Colville Brown, Medical Director, EGALET
- John Burke, President, INTERNATIONAL HEALTH FACILITY DIVERSION ASSOCIATION
- Theresa Cassidy, Vice President, Health Analytics, INFLEXXION
- Dan Cohen, Forum Chair, ABUSE DETERRENT COALITION, Executive Vice President, Government Relations, KEMPHARM
- Angela DeVeaugh-Geiss, Director, Epidemiology, PURDUE PHARMA
- Torben Elhauge, Director, Analytical Development, EGALET
- Janetta Iwanicki, Associate Medical Director, ROCKY MOUNTAIN POISON & DRUG CENTER / RADARS SYSTEM
- Ernest Kopecky, Vice President, Clinical Development, Head, Global Pain Medicine, TEVA
- Alexander Kraus, Vice President, Business Unit North America, GRUNENTHAL
- Gene Levinstein, CMO, LEHIGH VALLEY TECHNOLOGIES
- Edward Liao, Head of Regulatory Affairs, CARA THERAPEUTICS
- Karsten Lindhardt, Senior Vice President, Head of R&D, EGALET
- Angela Moore, Analytical Scientist, ALCAMI
- Peter J. Pitts, President, CENTER FOR MEDICINE IN THE PUBLIC INTEREST
- William Schmidt, CMO, ENSYSCE
- Beatrice Setnik, Vice President, Clinical Pharmacology, INC RESEARCH
- Marta Sokolowska, Vice President, Medical and External Affairs, DEPOMED
- Lynn Webster, Vice President, Scientific Affairs, PRA HEALTH SCIENCES
- Graham Wood, Executive Vice President, Phase I Clinical Development, ALTASCIENCES CLINICAL RESEARCH
Please fill in your name and email to receive the conference agenda of this event.
Conference Day One - Monday, November 6, 2017
Conference Day Two - Tuesday, November 7, 2017
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
This conference is aimed at biopharma and medical device professionals responsible for:
- Regulatory Affairs / Intelligence
- Epidemiology / Pharmacoepidemiology
- Abuse / Deterrent / Deterrence / Abuse deterrent / Abuse Deterrence
- Clinical Development / Operations / Affairs / Programs
- Risk Management / REMS
- Toxicology
- Drug Safety
- Pharmacology / Clinical Pharmacology / Safety Pharmacology
- CNS / Neuroscience
- Medical Affairs
- Scientific Affairs
- Formulations
- Analytical Development
- Pharmaceutical Development
- Clinical Development
- Preclinical Development
- R&D
- Quality
- Pharmacovigilance
- Pharmacoeconomics / Health Economics / Outcomes Research / HEOR
- Commercial Affairs
- Legal Affairs / Legal Counsel
This event is also of interest to:
- CROs
- Toxicology Specialists
- Drug Abuse Registry / Surveillance Specialists
- REMS / Pharmacovigilance Specialists
- Formulation Service Providers
- Pharmacokinetics Service Providers
- Abuse Liability Service Providers
- Regulatory Specialists
- Intellectual Property Service Providers
Venue
Hyatt Regency Bethesda1 Bethesda Metro Center
Bethesda, MD 20814
Located in the heart of downtown Bethesda, Maryland, Hyatt Regency Bethesda is ideal for both business and leisure travelers. Our contemporary luxury hotel delivers exceptional venues for meetings and social gatherings, comfortable guest rooms with deluxe amenities, and specialty dining options. We’re also within walking distance of corporate offices and the Metro, a very convenient mode of transportation situated directly below the hotel.
To make reservations, please call 1-888-421-1442 and request the negotiated rate for ExL’s November Meetings. To make reservations online
Click HereThe group rate is available until October 17, 2017. Please book your room early as rooms available at this rate are limited.
